Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol

Yu Chi Shen, Ravi Upadhyayula, Stephanie Cevallos, Ryan J. Messick, Tammy Hsia, Mathew P. Leese, Douglas M. Jewett, Daysha Ferrer-Torres, Therese M. Roth, Wolfgang Dohle, Barry V L Potter, Kate F. Barald